Differences between strains known to produce the same compounds were observed, likely due to differences in concentrations of the compounds produced and/or due to differences in the relative composition of secretions in strains producing multiple compounds.
In addition, non responders to mexiletine therapy have been occasionally observed, likely due to pharmacogenetic mechanisms (Desaphy et al., 2001, 2013a, 2013b, 2013c).
This survival benefit of reversal of RI seen in group 2 is observed likely due to their significantly lower rate of early mortality in comparison to group 3 (8 vs 17% P=0.004).
Fewer surgical adhesions after LT have also been observed, likely due to suppression of surgical adhesions by immunosuppressants [10, 11].
Small variations in spatial resolution across the FOV were observed, likely due to the geometry of the system.
No significant differences for adsorption capacity among catalysts were observed, likely due to similar surface areas (Table 1).
With repeated charge/self-discharge cycling, a decrease in self-discharge is observed, likely due to the depletion of active sites for carbon oxidation.
However, at 20 ppm HA significant inhibition was observed, likely due to shadowing of the catalyst, quenching of ROS or blocking active sites of TiO2.
While this corrected the majority of the offsets, some small deviations can be observed, likely due to small residual errors from scattered light.
Generally, substantial variation within the animals was observed, likely owing to biological variation and inherent difficulties in classifying the exact position of the content in the small intestine.
